Investment objective

The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
Off-Hours Price
Change
YTD change
Weight
149.86USD+1.42%+42.37%8.3%
271.19USD+2.01%+31.04%8.24%
66.92USD+0.16%+24.06%7.57%
28.55USD+0.32%+14.66%6.49%
259.99USD+1.39%+13.79%6.31%
239.35USD+2.02%+16.47%4.41%
216.04USD-0.28%+22.76%4.07%
1,160.00USD+0.28%+7.94%4.06%
823.82USD+3.10%+6.73%3.88%
149.92USD+2.45%+22.14%3.87%
In partnership with
TrackInsight
Date Price Change Volume
01/09/26 US$41.62 +0.64% 136,496
31/08/26 US$41.35 +0.05% 53,243
28/08/26 US$41.33 -1.60% 81,561
27/08/26 US$42.00 -0.61% 325,766
26/08/26 US$42.26 -1.17% 159,421

Description

US33738R8372
Total Expense Ratio 0.006
Asset Class Stocks
Geographical Zones
Sector
Currency
Provider
Underlying NASDAQ US Smart Pharmaceuticals Total Return Index - USD
Autres ETFs

Features and characteristics

Dividend Policy Distribution
Replication Method Physique
Jurisdiction
Date of creation
19/09/2016
Factor
Geographical Focus

Distribution

Retail investor

AuM evolution - 11/08/2026

AuM (USD) 1.14B
AuM 1M 1.14B
AuM 3 months 1.14B
AuM 6 months 1.14B
AuM 12 months 1.14B
  1. Stock Market
  2. ETF
  3. FTXH ETF